Status:

COMPLETED

Evaluation of the Role of Vitamin D in Reducing the Severity and Duration of Rotavirus Infection in Iraqi Children

Lead Sponsor:

University of Baghdad

Conditions:

Rotaviral Gastroenteritis

Eligibility:

All Genders

3-5 years

Phase:

NA

Brief Summary

The aim of this study is to evaluate the effect of vitamin D supplementation on the clinical outcomes including duration and severity of rotavirus-induced gastroenteritis in children that will be admi...

Detailed Description

Evaluation of effect of vitamin D supplementation on the clinical outcomes including duration and severity of rotavirus-induced gastroenteritis in children that will be admitted to the hospital. And t...

Eligibility Criteria

Inclusion

  • Children with confirmed rotavirus infection by rotavirus stool examination by rotavirus rapid test from CerTest BIOTEC company in Spain.
  • Serum vitamin D levels indicating deficiency (below 20 ng/mL)

Exclusion

  • Children with other major infections, severe dehydration or underlying health conditions.
  • Children with current vitamin D supplementation.

Key Trial Info

Start Date :

January 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 6 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT07167797

Start Date

January 1 2025

End Date

December 6 2025

Last Update

December 31 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

AL Kadhimia pediatric hospital

Baghdad, Baghdad Governorate, Iraq, 00964